Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Selecta

- PMLiVE

Sanofi pulls Lyxumia’s US filing

Says will resubmit diabetes drug for FDA approval in 2015

Pharma deals during August 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for August 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

Biogen Idec building

Biogen Idec to develop Parkinson’s drugs with Amicus

Companies will develop treatments to target genetic mutation

Biogen Idec building

Biogen Idec gets exclusive access to Isis’ neurology R&D

Fourth deal in two years with antisense specialist

Novartis building

Novartis signs cell therapy deal with Regenerex

Involves platform that could allow transplant patients to live without lifelong immunosuppression

- PMLiVE

Sanofi plans its mobile diabetes future

Next phase of iBGStar project will focus on wider connectivity

Pharma deals during July 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for July 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

China flag thumb

Sanofi drawn into Chinese corruption probe

Joins GSK, UCB, AZ , Lilly, Novo and Lundbeck as companies under scrutiny

- PMLiVE

Sanofi vaccine against GI ‘superbug’ starts phase III

Aims to protect against Clostridium difficile

Bayer symbol

Bayer to research cancer immunotherapies with Compugen

Will develop drugs that boost response of body’s immune system to tumours

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links